Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-27
DOI
10.1002/alz.12156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
- (2020) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment
- (2019) Mélanie Fortier et al. Alzheimers & Dementia
- Modified Ketogenic Diet Is Associated With Improved Cerebrospinal Fluid Biomarker Profile, Cerebral Perfusion, And Cerebral Ketone Body Uptake In Older Adults At-Risk For Alzheimer’s Disease: A Pilot Study
- (2019) Bryan J. Neth et al. NEUROBIOLOGY OF AGING
- Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study
- (2018) Nare Torosyan et al. EXPERIMENTAL GERONTOLOGY
- Prospective frequency correction using outer volume suppression-localized navigator for MR spectroscopy and spectroscopic imaging
- (2018) Chu-Yu Lee et al. MAGNETIC RESONANCE IN MEDICINE
- Long-term Effects of Galantamine Treatment on Brain Functional Activities as Measured by PET in Alzheimer's Disease Patients
- (2018) Connor Keller et al. JOURNAL OF ALZHEIMERS DISEASE
- Rasagiline for Amyotrophic Lateral Sclerosis: a Randomized Controlled Trial
- (2018) Jeffrey M Statland et al. MUSCLE & NERVE
- Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy
- (2017) Pravat K. Mandal et al. JOURNAL OF ALZHEIMERS DISEASE
- A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial
- (2017) Heather M. Wilkins et al. JOURNAL OF ALZHEIMERS DISEASE
- PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET – Application to amyloid imaging with AV45-PET
- (2017) Gabriel Gonzalez-Escamilla et al. NEUROIMAGE
- Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure
- (2016) Heather M. Wilkins et al. JOURNAL OF NEUROCHEMISTRY
- Bioenergetics and metabolism: a bench to bedside perspective
- (2016) Russell H. Swerdlow JOURNAL OF NEUROCHEMISTRY
- Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis
- (2016) In-Young Choi et al. Multiple Sclerosis Journal
- In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Michael Gejl et al. Frontiers in Aging Neuroscience
- Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis
- (2016) In-Young Choi et al. Multiple Sclerosis Journal
- Glutathione redox imbalance in brain disorders
- (2015) Feng Gu et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
- (2015) Zachary Macchi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease
- (2014) Keith N. Fargo et al. Alzheimers & Dementia
- Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis
- (2014) Heather M. Wilkins et al. HUMAN MOLECULAR GENETICS
- Glutathione and mitochondria
- (2014) Vicent Ribas et al. Frontiers in Pharmacology
- The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
- (2013) Russell H. Swerdlow et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Bioenergetic medicine
- (2013) Russell H Swerdlow BRITISH JOURNAL OF PHARMACOLOGY
- Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas
- (2012) Angela Ruban et al. INVESTIGATIONAL NEW DRUGS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Effect of Glutamate and Blood Glutamate Scavengers Oxaloacetate and Pyruvate on Neurological Outcome and Pathohistology of the Hippocampus after Traumatic Brain Injury in Rats
- (2011) Alexander Zlotnik et al. ANESTHESIOLOGY
- Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease
- (2011) Russell H. Swerdlow ANTIOXIDANTS & REDOX SIGNALING
- Oxaloacetate Decreases the Infarct Size and Attenuates the Reduction in Evoked Responses after Photothrombotic Focal Ischemia in the Rat Cortex
- (2009) David Nagy et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion
- (2008) Máté Marosi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now